This title appears in the Scientific Report :
2021
Please use the identifier:
http://hdl.handle.net/2128/27732 in citations.
Please use the identifier: http://dx.doi.org/10.3390/cancers13092093 in citations.
Use of PET Imaging in Neuro-Oncological Surgery
Use of PET Imaging in Neuro-Oncological Surgery
This review provides an overview of current applications and perspectives of PET imaging in neuro-oncological surgery. The past and future of PET imaging in the management of patients with glioma and brain metastases are elucidated with an emphasis on amino acid tracers, such as O-(2-[18F]fluoroethy...
Saved in:
Personal Name(s): | Holzgreve, Adrien (Corresponding author) |
---|---|
Albert, Nathalie L. / Galldiks, Norbert / Suchorska, Bogdana (Corresponding author) | |
Contributing Institute: |
Kognitive Neurowissenschaften; INM-3 |
Published in: | Cancers, 13 (2021) 9, S. 2093 - |
Imprint: |
Basel
MDPI
2021
|
DOI: |
10.3390/cancers13092093 |
Document Type: |
Review Journal Article |
Research Program: |
Decoding Brain Organization and Dysfunction |
Link: |
OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://dx.doi.org/10.3390/cancers13092093 in citations.
This review provides an overview of current applications and perspectives of PET imaging in neuro-oncological surgery. The past and future of PET imaging in the management of patients with glioma and brain metastases are elucidated with an emphasis on amino acid tracers, such as O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET). The thematic scope includes surgical resection planning, prognostication, non-invasive prediction of molecular tumor characteristics, depiction of intratumoral heterogeneity, response assessment, differentiation between tumor progression and treatment-related changes, and emerging new tracers. Furthermore, the role of PET using specific somatostatin receptor ligands for the management of patients with meningioma is discussed. Further advances in neuro-oncological imaging can be expected from promising new techniques, such as hybrid PET/MR scanners and the implementation of artificial intelligence methods, such as radiomics. |